Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
80 participants
OBSERVATIONAL
2014-01-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Genomic Study of Congenital Malformation
NCT01250613
A Research Proposal to Set up an Integrated National Data Bank and Monitoring System and to Establish the Indicators and Risk Factors for Chronic Kidney Disease
NCT01452360
ACE Gene Polymorphism and ARDS Outcome
NCT00155779
Retrospective Analysis of Renal Prognosis in Patients With Chronic Kidney Disease
NCT03201406
Evaluation of Fanconi Syndrome and Cystinosis
NCT00004350
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Clinical data include total kidney volume (TKV), TKV slope, eGFR, eGFR slope and other clinically relevant data.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Otsuka Pharmaceutical Co., Ltd.
INDUSTRY
Kyorin University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eiji Higashihara, MD
Professor of Department of Polycystic Kidney Research, Kyorin University School of Medicine.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eiji Higashihara, MD
Role: STUDY_CHAIR
Department of Polycystic Kidney Research, Kyorin University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Polycystic Kidney Research, Kyorin University School of Medicine
Mitaka, Tokyo, Japan
Department of Urology, Kyorin University Hospital
Mitaka, Tokyo, Japan
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Higashihara E, Horie S, Kinoshita M, Harris PC, Okegawa T, Tanbo M, Hara H, Yamaguchi T, Shigemori K, Kawano H, Miyazaki I, Kaname S, Nutahara K. A potentially crucial role of the PKD1 C-terminal tail in renal prognosis. Clin Exp Nephrol. 2018 Apr;22(2):395-404. doi: 10.1007/s10157-017-1477-7. Epub 2017 Oct 5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Kyorin-PKD-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.